BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36708576)

  • 21. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
    Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma.
    Sasahira T; Kirita T; Bhawal UK; Ikeda M; Nagasawa A; Yamamoto K; Kuniyasu H
    Virchows Arch; 2007 Mar; 450(3):287-95. PubMed ID: 17235565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.
    Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ
    Cancer Lett; 2001 Feb; 163(2):191-200. PubMed ID: 11165754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis-related prognosis in patients with oral squamous cell carcinoma-role of the VEGF +936 C/T polymorphism.
    Kämmerer PW; Al-Nawas B; Kalkan S; Liese J; Fruth K; Frerich B; Brieger J
    J Oral Pathol Med; 2015 Jul; 44(6):429-36. PubMed ID: 25213013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance.
    Aggarwal S; Devaraja K; Sharma SC; Das SN
    Clin Chim Acta; 2014 Sep; 436():35-40. PubMed ID: 24833243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β1/TβRII/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages.
    Sun H; Miao C; Liu W; Qiao X; Yang W; Li L; Li C
    Biochem Biophys Res Commun; 2018 Mar; 497(2):583-590. PubMed ID: 29462614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
    Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
    Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
    Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.
    Hwang-Bo J; Park JH; Bae MG; Chung IS
    Cancer Med; 2016 Oct; 5(10):2977-2988. PubMed ID: 27650585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Analysis of Vascular Endothelial Growth Factor Expression with Cyclooxygenase-2 and Mast Cell Density in Oral Squamous Cell Carcinoma.
    Akbarzadeh Baghban A; Taghavi N; Shahla M
    Pathobiology; 2017; 84(2):80-86. PubMed ID: 27577989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma.
    Escobar E; Gómez-Valenzuela F; Peñafiel C; Hormazábal-Hevia A; Herrera-Fuentes C; Mori-Aliaga D
    Rev Esp Patol; 2023; 56(3):147-157. PubMed ID: 37419553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of vascular endothelial growth factor gene -460 C/T polymorphism as a biomarker in oral squamous cell carcinoma patients from the Indian subcontinent.
    Borase AP; Ganvir SM; Hazarey VK; Gosavi SR; Mohatta AA; Singh J
    J Investig Clin Dent; 2015 Nov; 6(4):267-72. PubMed ID: 25051952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.